Pfizer Shares Top-Line Results From Phase 2/3 EPIC-PEP Study Of PAXLOVIDTM For Post-Exposure Prophylactic Use; Says Results Of Study Were Not Statistically Significant
PFEApril 29, 2022
Read more →This Is What Whales Are Betting On Pfizer
PFEA whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 17 strange trades.
April 29, 2022
Read more →Fauci Says There Is Anecdotal Evidence Of Some People Taking Pfizer's Oral Drug Paxlovid Have Shown Rebound In Either Test Positivity Or Mild Symptoms
PFEApril 29, 2022
Read more →FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
PFEApril 28, 2022
Read more →